KYMR
Kymera Therapeutics, Inc.
Stock
$107.39−2.73 (−2.48%)Close Oct 2, 2026
- Cash and short-term investments, 2025
- $848M
- YoY, 2025
- +73.6%
- 5-year CAGR
- +23.4%
Cash and short-term investments
Cash and short-term investments by fiscal year
| Period | Cash | YoY |
|---|---|---|
| 2025 | $848M | +73.6% |
| 2024 | $489M | +30.4% |
| 2023 | $375M | −7.9% |
| 2022 | $407M | −8.0% |
| 2021 | $442M | +49.4% |
| 2020 | $296M | +222.1% |
| 2019 | $92M | — |